Holen Sie sich die Stockscreener-App
6.90
5.67%
0.37
Handel nachbörslich:
6.90
Schlusskurs vom Vortag:
$6.53
Offen:
$6.59
24-Stunden-Volumen:
634.31K
Relative Volume:
1.67
Marktkapitalisierung:
$435.89M
Einnahmen:
$198.53M
Nettoeinkommen (Verlust:
$-63.68M
KGV:
-6.7501
EPS:
-1.0222
Netto-Cashflow:
$-41.50M
1W Leistung:
+26.14%
1M Leistung:
+15.00%
6M Leistung:
-31.55%
1J Leistung:
+13.67%
1-Tages-Spanne:
$6.345
$7.035
1-Wochen-Bereich:
$5.17
$7.035
52-Wochen-Spanne:
$4.54
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Vergleichen Sie TMCI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.90 | 403.68M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Arcadia Wealth Management Inc. Invests $1.76 Million in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Stifel Nicolaus Lowers Treace Medical Concepts (NASDAQ:TMCI) Price Target to $6.00 - MarketBeat
Investigation announced for Investors who hold shares of Treace - openPR.com
Treace Medical Concepts: Positive Q2 Earnings Call Highlights - TipRanks
SEC Filings Archive 2025-08-12Historical 10-K, 10-Q, 8-K Forms - Stock Titan
UBS Group Has Lowered Expectations for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Reach Out - ACCESS Newswire
Treace Medical anticipates 7–10% revenue growth in 2025 while launching next-gen bunion solutions - MSN
Treace Medical Concepts (NASDAQ:TMCI) Posts Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Analysts Have Been Trimming Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Price Target After Its Latest Report - Yahoo Finance
Insider Stock Buying Reaches US$1.80m On Treace Medical Concepts - 富途牛牛
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Just Reported, And Analysts Assigned A US$8.35 Price Target - simplywall.st
Why did TMCI's Q4 2024 EPS surprise investors? - AInvest
Health Check: How Prudently Does Treace Medical Concepts (NASDAQ:TMCI) Use Debt? - simplywall.st
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q2 2025 Earnings Call Transcript - Insider Monkey
Treace Medical Concepts Maintains Buy Rating with $12 Price Target: Analyst - AInvest
Treace Medical Concepts Inc (TMCI) Q2 2025 Earnings Call Highlights: Revenue Growth and ... By GuruFocus - Investing.com Canada
Treace Medical Concepts Trims Losses As Revenue Rises - Finimize
Treace Medical Concepts revenue up 7% to USD 47.4M in Q2 2025 - Medical Buyer
Treace Medical Concepts Reports Q2 2025 Financial Results - TipRanks
Treace Medical Concepts Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Treace Medical (TMCI) Q2 Revenue Up 7% - The Motley Fool
Treace Medical Concepts, Inc. shares rise 3.35% after-hours after Q2 revenue beats estimates. - AInvest
Treace Medical Concepts: Q2 Earnings Snapshot - San Antonio Express-News
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts Reports Second Quarter 2025 Financial Results - The Manila Times
Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025 - The Manila Times
Treace Medical to Showcase Revolutionary Bunion Surgery Innovations at Upcoming Investor Day - Stock Titan
GSA Capital Partners LLP Buys New Stake in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Important Notice to Long-Term Shareholders of Centene - GlobeNewswire
Treace Announces Peer-Reviewed Publication of Four-Year Results of the ALIGN3D™ Lapiplasty® Multicenter Prospective Clinical Study - The Manila Times
Revolutionary Bunion Surgery Success: New 4-Year Study Reveals 99.2% Non-Recurrence Rate for Lapiplasty - Stock Titan
Analyzing Treace Medical Concepts Inc. with risk reward ratio chartsStock Market Watch with Smart Filters - Newser
Is Treace Medical Concepts Inc. stock ready for a breakoutRSI and MACD Signal Summary with Trends - Newser
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives $10.52 Average PT from Analysts - MarketBeat
How to interpret RSI for Treace Medical Concepts Inc. stockConservative Equity Setup with Signal Analysis - Newser
What catalysts could drive Treace Medical Concepts Inc. stock higher in 2025Invest like a pro with expert recommendations - Jammu Links News
What drives Treace Medical Concepts Inc. stock priceUnlock powerful trading techniques - Jammu Links News
What is the risk reward ratio of investing in Treace Medical Concepts Inc. stockUnmatched market performance - Jammu Links News
How many analysts rate Treace Medical Concepts Inc. as a “Buy”Exceptional profit potential - Jammu Links News
Is Treace Medical Concepts Inc. a growth stock or a value stockFree Risk Assessment Services - Jammu Links News
Does Treace Medical Concepts Inc. stock perform well during market downturnsAchieve breakthrough performance with smart picks - Jammu Links News
Treace Medical Concepts (TMCI) to Release Earnings on Thursday - MarketBeat
What makes Treace Medical Concepts Inc. stock price move sharplyMaximize your portfolio’s earning power - Jammu Links News
What institutional investors are buying Treace Medical Concepts Inc. stockTremendous wealth creation - Jammu Links News
Is Treace Medical Concepts Inc. stock overvalued or undervaluedGet expert analysis on top stock picks - Jammu Links News
Is it the right time to buy Treace Medical Concepts Inc. stockUnlock exclusive stock market insights - Jammu Links News
Treace Medical Concepts Inc. Stock Analysis and ForecastInvest smarter with expert stock recommendations - Jammu Links News
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.07%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):